Nothing Special   »   [go: up one dir, main page]

DK0743851T3 - Lipofile bærepræparater - Google Patents

Lipofile bærepræparater

Info

Publication number
DK0743851T3
DK0743851T3 DK95909185T DK95909185T DK0743851T3 DK 0743851 T3 DK0743851 T3 DK 0743851T3 DK 95909185 T DK95909185 T DK 95909185T DK 95909185 T DK95909185 T DK 95909185T DK 0743851 T3 DK0743851 T3 DK 0743851T3
Authority
DK
Denmark
Prior art keywords
polar
pct
pharmaceutical composition
relates
polar lipid
Prior art date
Application number
DK95909185T
Other languages
Danish (da)
English (en)
Inventor
Anders Carlsson
Bengt Hersloef
Original Assignee
Lipocore Holding Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9400368A external-priority patent/SE9400368D0/xx
Priority claimed from SE9402456A external-priority patent/SE517678C2/sv
Application filed by Lipocore Holding Ab filed Critical Lipocore Holding Ab
Application granted granted Critical
Publication of DK0743851T3 publication Critical patent/DK0743851T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/064Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053Compositions other than spreads
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L35/00Foods or foodstuffs not provided for in groups A23L5/00 - A23L33/00; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95909185T 1994-02-04 1995-02-06 Lipofile bærepræparater DK0743851T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9400368A SE9400368D0 (sv) 1994-02-04 1994-02-04 Glycolipid material
SE9402456A SE517678C2 (sv) 1994-07-12 1994-07-12 Lipofila bärarpreparat med en kontinuerlig lipidfas
PCT/SE1995/000117 WO1995020945A1 (en) 1994-02-04 1995-02-06 Lipophilic carrier preparations

Publications (1)

Publication Number Publication Date
DK0743851T3 true DK0743851T3 (da) 2001-09-03

Family

ID=26661956

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95909185T DK0743851T3 (da) 1994-02-04 1995-02-06 Lipofile bærepræparater

Country Status (19)

Country Link
US (1) US5716639A (de)
EP (1) EP0743851B1 (de)
JP (1) JP3203359B2 (de)
KR (1) KR100220546B1 (de)
CN (1) CN1091591C (de)
AT (1) ATE201980T1 (de)
AU (1) AU691250B2 (de)
CA (1) CA2182577C (de)
DE (1) DE69521300T2 (de)
DK (1) DK0743851T3 (de)
ES (1) ES2158084T3 (de)
FI (1) FI963066A (de)
HU (1) HU221432B (de)
MY (1) MY112435A (de)
NO (1) NO312495B1 (de)
NZ (1) NZ279954A (de)
PL (1) PL178394B1 (de)
TW (1) TW482685B (de)
WO (1) WO1995020945A1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
CA2253358C (en) * 1996-05-10 2007-12-04 Yamanouchi Europe B.V. Powder containing reversed vesicles comprising one or more non-ionic surfactants
DE69732239T2 (de) * 1996-05-10 2005-12-22 Unilever N.V. Flüssige fettverbindung enthaltende zusammensetzung
GR1002706B (el) * 1996-05-22 1997-05-26 Μικρογαλακτωματα λεκιθινης περιεχοντα πρωτεολυτικα ενζυμα α-χυμοθρυψινης η θρυψινη και μεθοδος μονιμης ενζυμικης αποτριχωσης.
DE19645657A1 (de) * 1996-11-06 1998-05-28 Rhone Poulenc Rorer Gmbh Phospholipidische Zusammensetzung, Verfahren zur Herstellung einer derartigen Zusammensetzung und Verwendung derselben
SE9702630D0 (sv) * 1997-07-07 1997-07-07 Scotia Lipidteknik Ab Satiety product
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
DE19819273A1 (de) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
EP1043016B1 (de) 1999-03-30 2014-08-20 Sodic Sa Pflanzenextrakt auf Glycerid-, Phospholipid- und Phytosphingolipidbasis, Verfahren für die Gewinnung dieses Extrakts und ihn enthaltende kosmetische Zusammensetzungen
US6916488B1 (en) * 1999-11-05 2005-07-12 Biocure, Inc. Amphiphilic polymeric vesicles
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
EP1151745A1 (de) * 2000-05-05 2001-11-07 L'oreal Wasser-in-Öl Emulsion und deren Verwendung in Kosmetika
WO2003035112A1 (fr) * 2001-10-22 2003-05-01 Jiro Kanie Nutriant enteral et procede de production de celui-ci
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
SE0300207D0 (sv) 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition
US7824706B2 (en) 2003-05-09 2010-11-02 Freedom Health, Llc Dietary supplement and method for the treatment of digestive tract ulcers in equines
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7658964B2 (en) * 2003-05-09 2010-02-09 Freedom Health, Llc Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
ES2258694T3 (es) 2003-11-11 2006-09-01 Mattern, Udo Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales.
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
WO2005053612A2 (en) * 2003-11-26 2005-06-16 Shire Laboratories, Inc. Micellar systems useful for delivery of lipophilic or hydrophobic compounds
CN101142233A (zh) 2004-12-22 2008-03-12 利波佩普蒂德有限公司 抑制cathelin样蛋白hCAP18/LL-17的试剂
BRPI0608444A2 (pt) * 2005-03-04 2009-12-29 Dsm Ip Assets Bv composição lipìdica particulada alimentìcia
DE102005023638A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt an Glucosylglyceriden und einem oder mehreren Acrylamidomethylpropylsulfonsäure-Polymeren
DE102005023636A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin
DE102005023640A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
AU2006291588A1 (en) * 2005-09-16 2007-03-22 Dsm Ip Assets B.V. Particulate lipid pharmaceutical composition
RU2480208C2 (ru) 2006-10-04 2013-04-27 М Унд П Патент Акциенгезелльшафт Система доставки с контролируемым высвобождением для назального применения нейротрансмиттеров
CN101827578B (zh) * 2007-08-09 2012-10-31 花王株式会社 反相囊泡组合物
US20090137497A1 (en) * 2007-11-23 2009-05-28 Beiersdorf Ag Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine
US20090285869A1 (en) * 2008-05-14 2009-11-19 Humco Holding Group, Inc. Salt stable lecithin organogel composition
JP2010104946A (ja) * 2008-10-31 2010-05-13 Riso Kagaku Corp 逆ベシクルを用いて形成された油中水(w/o)型エマルション
CN101787059B (zh) * 2009-05-12 2014-10-15 沈阳药科大学 双半乳糖基二酰甘油酯的制备方法及其应用
PL2550020T3 (pl) * 2010-03-24 2015-12-31 Medesis Pharma Mikroemulsja odwróconych miceli zawierających jony metali i jej zastosowanie
US9237762B2 (en) * 2010-05-24 2016-01-19 Swedish Oat Fiber Ab Aqueous dispersion comprising galactolipids and method for production thereof
EP2389816A1 (de) * 2010-05-25 2011-11-30 Nestec S.A. Synergistische Antioxidanszusammensetzung
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
JP6242582B2 (ja) * 2013-04-01 2017-12-06 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法
JP6242581B2 (ja) * 2013-04-01 2017-12-06 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法
WO2014103742A1 (ja) * 2012-12-25 2014-07-03 ポーラ化成工業株式会社 逆ベシクル組成物及びその製造方法
JP6239822B2 (ja) * 2012-12-27 2017-11-29 ポーラ化成工業株式会社 逆ベシクル組成物
JP6334151B2 (ja) * 2012-12-25 2018-05-30 ポーラ化成工業株式会社 逆ベシクル組成物
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
KR20160002929A (ko) * 2013-04-16 2016-01-08 다우 글로벌 테크놀로지스 엘엘씨 저지방 라미네이트된 도우 및 패스트리
WO2020237383A1 (en) * 2019-05-31 2020-12-03 Groupe Santé Devonian Inc. Thylakoids as delivery system for cannabinoïds and other molecules and formulations thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009842B1 (de) * 1978-10-02 1982-11-10 THE PROCTER & GAMBLE COMPANY Liposome zur Freigabe von Arzneimitteln und eine ein Arzneimittelsystem mit liposomen enthaltende Bereitung
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
ES2036593T3 (es) * 1986-06-12 1993-06-01 The Liposome Company, Inc. Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
US5234767A (en) * 1987-03-13 1993-08-10 Micro-Pak, Inc. Hybrid paucilamellar lipid vesicles
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
JP2774429B2 (ja) * 1992-03-17 1998-07-09 株式会社ディ・ディ・エス研究所 糖骨格を有する分枝鎖型誘導体

Also Published As

Publication number Publication date
NO963242L (no) 1996-08-02
FI963066A (fi) 1996-09-30
EP0743851A1 (de) 1996-11-27
CN1091591C (zh) 2002-10-02
HU9602142D0 (en) 1996-09-30
PL178394B1 (pl) 2000-04-28
ATE201980T1 (de) 2001-06-15
AU1723595A (en) 1995-08-21
NO963242D0 (no) 1996-08-02
US5716639A (en) 1998-02-10
CA2182577A1 (en) 1995-08-10
HUT75470A (en) 1997-05-28
JP3203359B2 (ja) 2001-08-27
DE69521300T2 (de) 2002-05-02
HU221432B (en) 2002-10-28
FI963066A0 (fi) 1996-08-02
PL315780A1 (en) 1996-12-09
NZ279954A (en) 1998-02-26
CA2182577C (en) 2002-08-20
ES2158084T3 (es) 2001-09-01
DE69521300D1 (de) 2001-07-19
JPH09508415A (ja) 1997-08-26
AU691250B2 (en) 1998-05-14
WO1995020945A1 (en) 1995-08-10
KR100220546B1 (ko) 1999-09-15
TW482685B (en) 2002-04-11
NO312495B1 (no) 2002-05-21
EP0743851B1 (de) 2001-06-13
CN1140405A (zh) 1997-01-15
MY112435A (en) 2001-06-30

Similar Documents

Publication Publication Date Title
DK0743851T3 (da) Lipofile bærepræparater
TW288979B (de)
MY113341A (en) Bilayer preparations
ATE307492T1 (de) Wirkstoff enthaltende geschmackmodifizierte harte konfektprodukte
MY131380A (en) Fatty ingredients & products for full or partial replacement of fat in food products
ATE221369T1 (de) Emulsion enthaltend eine gelierte wässerige aüssere phase, eine nichtwässerige zwischenphase und eine wässerige innere phase
RU95102782A (ru) Косметические композиции для местного применения, вызывающие искусственный загар, способ их получения и применение
AU5178193A (en) Solubilizing agents
DE69114922D1 (de) Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten.
SE9402454L (sv) Olja-i-vatten-emulsioner
SE9402456L (sv) Lipofila bärarpreparat
ATE206036T1 (de) Kombination eines zinksalicylats und eines serenoa repens-extrakts zur behandlung der seborrhö und diese enthaltende kosmetische hautpflegemittel